Evidence map›Paper›PMID 32291648›Full record

ReviewAdvances in therapy2020

Central Neuropathic Mechanisms in Pain Signaling Pathways: Current Evidence and Recommendations.

Omar Viswanath, Ivan Urits, James Burns, Karina Charipova, Kyle Gress, Alexandra McNally, Richard D Urman, Ali Welschmeyer, Amnon A Berger, Hisham Kassem and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Drug design, development and therapy · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Omar ViswanathValley Anesthesiology and Pain Consultants-Envision Physician Services, Phoenix, AZ, USA.
Ivan UritsBeth Israel Deaconess Medical Center, Department of Anesthesiology, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA, USA. ivanurits@gmail.com.
James BurnsGeorgetown University School of Medicine, Washington, DC, USA.
Karina CharipovaGeorgetown University School of Medicine, Washington, DC, USA.
Kyle GressGeorgetown University School of Medicine, Washington, DC, USA.
Alexandra McNallyGeorgetown University School of Medicine, Washington, DC, USA.
Richard D UrmanDepartment of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Ali WelschmeyerGeorgetown University School of Medicine, Washington, DC, USA.
Amnon A BergerBeth Israel Deaconess Medical Center, Department of Anesthesiology, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA, USA.
Hisham KassemDepartment of Anesthesiology, Mount Sinai Medical Center, Miami Beach, FL, USA.
Manuel G SanchezDepartment of Pain Medicine, Pain Specialty Group, Newington, NH, USA.
Alan D KayeDepartment of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, USA.
Treniece N EubanksDepartment of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, USA.
Elyse M CornettDepartment of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, USA.
Anh L NgoDepartment of Pain Medicine, Pain Specialty Group, Newington, NH, USA.
Georgetown University · USLouisiana State University in Shreveport · USChildren's Specialty Group · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USCreighton University · USHarvard University · USMount Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis is a comprehensive review of the current literature on central neuropathic pain mechanisms that is secondary to spinal cord injury. It reviews recent and seminal findings on the pathophysiology, diagnosis, and treatment and compares treatment options and recommendations. RECENT

findingsNeuropathic pain (NP) is a common complication of spinal cord injury (SCI). Chronicity of NP is attributed to increased abundance of inflammatory mediators and ion channel dysfunction leading to afferent nerve sensitization; nerve damage and nerve-glia cross talk have also been implicated. Conventional treatment is medical and has had limited success. Recent studies have made headway in identifying novel biomarkers, including microRNA and psychosocial attributes that can predict progress from SCI to chronic NP (CNP). Recent advances have provided evidence of efficacy for two promising drugs. Baclofen was able to provide good, long-lasting pain relief. Ziconotide, a voltage-gated calcium channel blocker, was studied in a small trial and was able to provide good analgesia in most participants. However, several participants had to be withdrawn because of worrisome creatine phosphokinase (CPK) elevations, and further studies are required to define its safety profile. Non-medical interventions include brain sensitization and biofeedback techniques. These methods have recently had encouraging results, albeit preliminary. Case reports of non-conventional techniques, such as hypnosis, were also reported. CNP is a common complication of SCI and is a prevalent disorder with significant morbidity and disability. Conventional medical treatment is limited in efficacy. Recent studies identified baclofen and ziconotide as possible new therapies, alongside non-medical interventions. Further research into the pathophysiology is required to identify further therapy candidates. A multidisciplinary approach, including psychosocial support, medical and non-medical interventions, is likely needed to achieve therapeutic effects in this difficult to treat syndrome.

Indexed as

AnalgesicsCalcium Channel BlockersHumansNeuralgiaNeurogliaomega-ConotoxinsPain ManagementSpinal Cord InjuriesAnalgesicsCalcium Channel Blockersomega-ConotoxinsziconotideAllodyniaBaclofenCentral neuropathic painChronic painSpinal cord injuryZiconotide

Identifiers

PMID32291648
PMCPMC7467462
OpenAlexW3015685851

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.